Hussman Strategic Advisors, Inc. Vaxart, Inc. Transaction History

Hussman Strategic Advisors, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 02, 2020	SELL	$4.78 - $16.97 $956,000 - $3.39 Million	-200,000 Closed	0 $0
Q2 2020 Jul 31, 2020	SELL	$1.68 - $8.85 $504,000 - $2.66 Million	-300,000 Reduced 60.0%	200,000 $1.77 Million
Q1 2020 May 01, 2020	BUY	$0.34 - $2.87 $170,000 - $1.44 Million	500,000 New	500,000 $885,000

Ticker VXRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,506,000
Market Cap $40.5M
Description
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...

Get notified when there are updates to the investment portfolio of Hussman Strategic Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Hussman Strategic Advisors, Inc. with notifications on news.